Top Contributors Empowering Healthcare | MD Tech Review

EUROPE

Contributors

USING TECHNOLOGY TO ADVANCE POPULATION HEALTH STRATEGIES

Patrick Young, President of Population Health, Hackensack Meridian Health

How One Unique Certified Home Health Agency Formed a Special Relationship with One World-Class New York City Hospital System

Jack Bron, VP of Strategic Partnerships, Centers Choice Home Care

During this COVID-19 pandemic, whenever nurses found it difficult to come to work, NYU always knew Revival Home...

Day in the Life of COVID Reporting

Amber Theel, System Director - Patient Safety and Quality, Adventist Health

The end game is to understand the disease, its prevalence, the resources needed to keep everyone safe and hopefully...

Disrupting the CIO Comfort Zone

Wes Williams, VP & CIO, Mental Health Center of Denver

It’s crucial to break out from the everyday expectations to imagine a better way. Embrace disruption to transform...

Healthcare Quality: Who is in charge and why?

Steve Tierney MD, Sr. Medical Director Quality Improvement, South central Foundation

Every healthcare organization has a quality department.

Integrating Telehealth in the Care Continuum

Kristin Myers, Chief Information Officer, Mount Sinai Health System

Technology is now more important than ever. COVID-19 has clearly accelerated the need for technology and at the same time, highlighted the challenges we still have with technology.

Managed Care World without Prior Authorizations is a Win-Win for All Parties Lessons reinforced by COVID-19 & the "No Auth" Business Model

Franklin Segura, Vice President of Managed Care, Centers Health Care

Typically, when a provider and health plan agree to go with the no prior authorization methodology, the health plan will require a monthly summary of the cases the provider has accepted.

Revamping Workflow in Pharma Industry with Technology

Bozidar Jovicevic, VP, Global Head of Digital Therapeutics, Sanofi [EPA:SAN]

Technology has aided the pharma and life sciences industry in employing genomics and artificial intelligence (AI) for speeding up drug R&D course

Progressive Innovation Improving Patient Outcomes

Emanuele Degortes, Head of Patient, Innovation and Access Policy, Vifor Pharma

Companies are starting to realise the impact that patients and patient associations can have along the entire life cycle of their products, from regulatory filing, to market access

How AI will change translational research in pharma clinical development

James Cai, Head of Data Science, Roche

To fully realize the power of AI, it is important for both pharma and academia to invest in research at the intersection of AI and biomedicine. It is also imperative to systematically generate high quality, properly labeled data.